|
시장보고서
상품코드
1384907
세계의 의료용 트라이코더 시장 규모, 점유율, 산업 동향 분석 리포트 : 용도별, 유형별, 지역별 전망과 예측(2023-2030년)Global Medical Tricorder Market Size, Share & Industry Trends Analysis Report By Application (Diagnosis, Monitoring and Others), By Type (Wireless, USB Camera, Fiber Optic Camera, Corded and Others), By Regional Outlook and Forecast, 2023 - 2030 |
||||||
의료용 트라이코더 시장 규모는 2030년까지 77억 달러에 달하며, 예측 기간 중 CAGR은 9.1%의 시장 성장률로 상승할 것으로 예측됩니다.
팬데믹은 세계 공급망을 혼란에 빠뜨려 의료용 트리코더의 생산과 유통에 영향을 미쳤습니다. 부품 조달 및 제조 지연은 때때로 이러한 장비의 가용성을 방해하여 의료 시설이 이 기술에 접근하는 능력에 영향을 미쳤습니다. 또한 의료시설이 COVID-19 환자 관리와 치료에 큰 어려움을 겪으면서 팬데믹 기간 중 환자 원격 모니터링과 진단의 필요성이 더욱 분명해졌습니다. 진단 데이터를 원격으로 수집하고 전송할 수 있는 의료용 트리코더는 직접 접촉하지 않고도 환자를 모니터링하고 바이러스 감염 위험을 줄이기 위해 수요가 증가하고 있으며, COVID-19 사례를 식별할 수 있는 신속하고 정확한 진단 툴의 긴급한 필요성도 시장의 기술 혁신을 촉진했습니다.
그러나 규제 당국의 승인 절차는 시간이 오래 걸리며, 종종 몇 년이 걸리기도 합니다. 이로 인해 의료용 트리코더의 개발 및 상용화가 크게 지연되어 새롭고 혁신적인 기기 시장 출시가 늦어질 수 있습니다. 규제 요건을 준수하기 위해서는 대규모 시험, 임상시험 및 문서화가 필요한 경우가 많습니다. 이러한 활동은 개발 비용을 크게 증가시켜 결국 기기 가격 상승을 통해 소비자에게 전가될 수 있습니다. 소규모의 혁신적인 스타트업은 규제 당국의 승인과 관련된 높은 비용과 복잡성으로 인해 시장 진입에 큰 어려움을 겪을 수 있습니다. 이로 인해 시장 경쟁과 혁신이 제한될 수 있습니다.
용도 전망
용도에 따라 시장은 모니터링, 진단 및 기타로 분류됩니다. 진단 부문은 2022년 시장에서 가장 큰 매출 점유율을 차지할 것으로 예상됩니다. 의료용 트리코더는 활력 징후와 매개변수를 측정할 수 있는 센서를 통합하는 방식으로 발전해 왔습니다. 이러한 센서에는 심전도(ECG), 체온, 혈압, 호흡수 등이 포함됩니다. 멀티모달 센서의 통합은 트리코더의 진단 능력을 강화하여 종합적인 건강 평가를 가능하게 합니다. 나노기술과 랩온칩 기술의 통합은 진단학에 혁명을 일으켰습니다. 의료용 트리코더는 이제 질병, 병원체 및 바이오마커를 분자 수준에서 매우 높은 감도로 감지할 수 있습니다. 이러한 높은 정확도는 질병을 조기에 발견하고 모니터링할 수 있으며, 환자 결과를 크게 개선할 수 있습니다. 따라서 이러한 요인들은 이 부문 수요를 증가시킬 것입니다.
유형별 전망
유형별로 시장은 무선, USB 카메라, 광섬유 카메라, 유선, 기타로 구분되며, 2022년에는 유선 부문이 시장에서 상당한 매출 점유율을 차지할 것으로 예상됩니다. 유선 트리코더는 전원 및 데이터 전송에 직접적이고 일관된 연결을 통해 더 높은 정확도와 신뢰성을 제공합니다. 이는 의료 진단에서 매우 중요합니다. 일부 지역에서는 엄격한 데이터 보안과 정확성을 요구하는 특정 규제 기준이 있을 수 있습니다. 코드형 트리코더는 이러한 규제를 준수하기 때문에 선호될 수 있습니다. 유선 트리코더는 지속적인 전원 공급과 끊김 없는 연결성을 제공하므로 배터리 수명이나 무선 연결 문제와 관련된 우려가 없습니다. 유선 연결은 무선 옵션에 비해 더 빠르고 안정적인 데이터 전송 속도를 제공할 수 있는 경우가 많습니다. 따라서 이러한 요인들은 유선 부문의 성장을 가속할 것으로 보입니다.
최종사용자별 전망
최종사용자별로 보면 시장은 병원, 클리닉, 기타로 나뉩니다. 병원 부문은 2022년 시장에서 가장 큰 매출 점유율을 기록했습니다. 병원과 외래수술센터(ASC)는 환자에게 최상의 치료를 제공하기 위해 최선을 다하고 있습니다. 의료용 트리코더는 진단 능력을 향상시켜 의료 전문가가 다양한 질병을 신속하고 정확하게 진단할 수 있도록 도와줍니다. 이 기술은 신속한 진단이 생사를 가르는 응급실에서 특히 유용합니다. 메디컬 레코더는 의료 시설의 워크플로우를 크게 간소화할 수 있습니다. 의료 서비스 프로바이더는 환자의 혼란을 최소화하면서 신속하게 진단 데이터를 수집할 수 있습니다. 이러한 효율성은 바쁜 병원이나 외래수술센터(ASC)와 같이 시간이 촉박하게 돌아가는 의료 현장에서 특히 유용합니다. 이러한 요인으로 인해 이 분야 수요는 증가할 것으로 보입니다.
지역별 전망
지역별로 보면 시장은 북미, 유럽, 아시아태평양, LAMEA로 나뉩니다. 북미 부문은 2022년 시장에서 가장 높은 매출 점유율을 차지할 것으로 예상됩니다. 북미는 고령화가 진행되면서 헬스케어 서비스에 대한 수요가 증가하고 있습니다. 의료용 트리코더는 건강 상태를 모니터링하는 보다 효율적이고 편리한 방법을 제공하여 의료 시스템의 부담을 줄일 수 있습니다. 의료용 트래커는 당뇨병, 고혈압, 심장병과 같은 장기적인 상태를 지속적으로 모니터링하는 데 유용합니다. 이러한 질환을 앓고 있는 사람들이 증가함에 따라 효과적인 원격 모니터링 툴에 대한 수요가 증가하고 있습니다. 따라서 이 분야는 향후 수요가 증가할 것으로 예상됩니다.
The Global Medical Tricorder Market size is expected to reach $7.7 billion by 2030, rising at a market growth of 9.1% CAGR during the forecast period.
Medical tricorders have become more sophisticated, accurate, and user-friendly as technology advances. European consumers and healthcare providers are increasingly interested in adopting these cutting-edge devices to improve patient care and health monitoring. Therefore, the European region would account for 2/5th share of the market by 2030. The rise of telemedicine and telehealth services in Europe has created a demand for tools that enable patients and healthcare providers to collect and share medical data remotely. Owing to these aspects, there will be a rise in demand in the Europe segment. Some of the factors impacting the market are rising technological advancements in medical devices, increasing proactive engagement of patients in managing their health, and strict regulatory requirements and the process of obtaining approvals.
Advances in sensor miniaturization have allowed for integrating various sensors into small, handheld devices. This includes sensors for measuring temperature, blood pressure, heart rate, and oxygen levels. These sensors are now compact, highly accurate, and energy-efficient. Modern sensors can detect subtle physiological parameter changes, making them suitable for clinical use. They can provide accurate measurements in real-time, which is crucial for monitoring health conditions and diagnosing illnesses. Tricorders can collect, process, and display health data in real-time, enabling immediate feedback to healthcare providers and patients. This real-time capability is crucial for making rapid clinical decisions and adjustments in treatment plans. Additionally, the need for devices and technology that help people track their health is growing as people take greater ownership of their health and well-being. Medical tricorders cater to this demand by providing a user-friendly, at-home health monitoring solution. Medical tricorders empower individuals to monitor their vital signs and health parameters regularly. This early detection of potential issues can lead to timely interventions and better health outcomes. With individuals actively using medical tricorders, a wealth of data is available for analysis. This data can be integrated into electronic health records, providing a more comprehensive view of a patient's health history. It can also enable personalized healthcare recommendations and interventions based on the individual's unique health data. Owing to these factors, the demand for medical tricorders will increase.
The pandemic disrupted global supply chains, impacting the production and distribution of medical tricorders. Delays in component sourcing and manufacturing occasionally hampered the availability of these devices, affecting healthcare facilities' ability to access this technology. Moreover, the need for remote patient monitoring and diagnosis became more apparent during the pandemic, as healthcare facilities faced significant challenges in managing and treating COVID-19 patients. With their ability to remotely collect and transmit diagnostic data, medical tricorders saw increased demand to monitor patients without direct contact, reducing the risk of virus transmission. The urgent need for rapid and accurate diagnostic tools to identify COVID-19 cases also prompted innovation in the market.
However, the regulatory approval process can be time-consuming, often taking several years. This can significantly delay the development and commercialization of medical tricorders, slowing the introduction of new and innovative devices to the market. Complying with regulatory requirements often requires extensive testing, clinical trials, and documentation. These activities can significantly increase development costs, ultimately passed on to consumers through higher device prices. Small and innovative startups may face substantial challenges entering the market due to the high costs and complexities associated with regulatory approval. This can limit competition and innovation within the market.
Application Outlook
Based on application, the market is segmented into monitoring, diagnosis, and others. The diagnosis segment held the largest revenue share in the market in 2022. Medical tricorders have evolved to incorporate sensors capable of measuring vital signs and parameters. These sensors include electrocardiography (ECG), temperature, blood pressure, and respiratory rate. Integrating multi-modal sensors enhances tricorders' diagnostic capabilities, allowing for comprehensive health assessments. The integration of nanotechnology and lab-on-a-chip technology has revolutionized diagnostics. Medical tricorders can now detect diseases, pathogens, and biomarkers with exceptional sensitivity at the molecular level. This level of precision enables early disease detection and monitoring, significantly improving patient outcomes. Therefore, these factors will boost the demand in the segment.
Type Outlook
By type, the market is divided into wireless, USB camera, fiber optic camera, corded, and others. In 2022, the corded segment acquired a considerable revenue share in the market. Corded tricorders offer higher accuracy and reliability due to the direct and consistent connection to power sources and data transmission. This can be crucial in medical diagnostics. Depending on the region, certain regulatory standards may require stringent data security and accuracy. Corded tricorders might be favored due to their compliance with such regulations. Corded tricorders have a continuous power supply and uninterrupted connectivity, eliminating concerns related to battery life or wireless connectivity issues. Wired connections can often provide faster and more stable data transfer speeds compared to wireless options. Therefore, these factors will boost the expansion of the corded segment.
End-user Outlook
On the basis of end-user, the market is divided into hospitals, clinics, and others. The hospitals segment recorded the maximum revenue share in the market in 2022. Hospitals and ambulatory surgical centers are keen on providing the best possible care to their patients. Medical tricorders offer improved diagnostic capabilities, allowing healthcare professionals to quickly and accurately diagnose various medical conditions. This technology is especially valuable in emergency rooms, where rapid diagnosis can be a matter of life and death. Medical tricorders can significantly streamline the workflow within healthcare facilities. They enable healthcare providers to collect diagnostic data rapidly and with minimal patient disruption. This efficiency is especially valuable in busy hospital settings and ambulatory surgical centers where time is often of the essence. Owing to these factors, there will be increased demand in the segment.
Regional Outlook
By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. The North American population is aging, leading to an increased demand for healthcare services. Medical tricorders offer a more efficient and convenient way to monitor health conditions, which can reduce the burden on healthcare systems. Medical tricorders are useful for ongoing surveillance of long-term conditions such as diabetes, high blood pressure, and heart disease. With a growing number of people living with these conditions, the demand for effective remote monitoring tools is rising. Therefore, the segment will witness increased demand in the future.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Healthy.io Ltd., Ionis Pharmaceuticals, Inc., Fujikura Ltd., Basler AG, Qualcomm, Inc., Hamamatsu Photonics K.K., Basil Leaf Technologies, DynoSense Corp, Cloud DX Inc., and QuantuMDx Group Limited.
Strategies Deployed in Medical Tricorder Market
Oct-2023: Qualcomm, Inc. came into partnership with Alphabet's Google, an American multinational technology company. This partnership aimed to manufacture wearable devices like smartwatches using chips based on RISC-V technology.
Jun-2023: Qualcomm Technologies, Inc. launched the Qualcomm Video Collaboration Platform, a new suite of video collaboration solutions. The launched product would enable original equipment manufacturers (OEMs) to design and deploy video conferencing products featuring superior video, audio, and customizable on-device AI to power engaging, immersive virtual meeting experiences across enterprise, healthcare, educational, and home environments.
May-2023: Healthy.io Ltd. came into collaboration with Boehringer Ingelheim Pharmaceuticals, Inc., a leading research-driven pharmaceutical company. This collaboration aimed to help at-home testing and provide educational information for patients at risk of chronic kidney disease (CKD).
Oct-2022: Cloud DX Inc. partnered with CBI Health, Canada's leading community healthcare provider. This partnership aimed to integrate Cloud DX expertise in remote and virtual care with CBI Health's professional and personal healthcare services and hospitals could discharge patients earlier with confidence.
Aug-2022: Cloud DX Inc. partnered with Teladoc Health, the global leader in whole-person virtual care. This partnership aimed to better serve the remote monitoring needs of patients across Canada.
Feb-2022: Healthy.io Ltd. partnered with Seed Group, a company of the private office of Sheikh Saeed bin Ahmed Al Maktoum. This partnership aimed to expand Healthy.io portfolios in the UAE.
Dec-2021: Cloud DX Inc. signed an agreement with Medtronic Canada ULC, a subsidiary of Medtronic plc. This agreement aimed to involve the enrollment of a chronic care or surgical patient onto the Connected HealthTM platform, generating recurring revenue, depending on the length of the monitoring program.
Dec-2020: Qualcomm, Inc. collaborated with trinamiX, a global solution provider specializing in Oracle Applications. This collaboration aimed to develop an IR spectrometer for smartphones, one step closer to Star Trek's tricorders.
Sep-2020: Cloud DX Inc. unveiled an updated Connected Health Kit, alongside a new quick-start program. The launched product would allow health providers and care teams to widen remote patient monitoring quickly and cost-effectively.
Jun-2020: Healthy.io Ltd. acquired Inui Health., a smartphone urinalysis startup. Under this acquisition, both companies aimed to build their product around the existing dipstick and technology.
Market Segments covered in the Report:
By Application
By Type
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research